Expression of soluble moloney murine leukemia virus-reverse transcriptase in Escherichia coli BL21 star (DE3) using autoinduction system
Molecular Biology Reports · 2024-12 · 51 (1)
DOI: 10.1007/s11033-024-09583-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 08.05.2024. Verfasst von Christina Vivid Handayani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Applied Microbiology, National Agency for Research and Innovation, Jl. Raya Bogor, Km. 46, Cibinong, Bogor, 16911, Indonesia. Hauptthemen laut MEDLINE: Escherichia coli, Moloney murine leukemia virus, RNA-Directed DNA Polymerase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Lembaga Pengelola Dana Pendidikan.
Abstract (Originalsprache)
Autoinduction systems in Escherichia coli can control the production of proteins without the addition of a particular inducer. In the present study, we optimized the heterologous expression of Moloney Murine Leukemia Virus derived Reverse Transcriptase (MMLV-RT) in E. coli. Among 4 autoinduction media, media Imperial College resulted the highest MMLV-RT overexpression in E. coli BL21 Star (DE3) with incubation time 96 h. The enzyme was produced most optimum in soluble fraction of lysate cells. The MMLV-RT was then purified using the Immobilized Metal Affinity Chromatography method and had specific activity of 629.4 U/mg. The system resulted lower specific activity and longer incubation of the enzyme than a classical Isopropyl ß-D-1-thiogalactopyranoside (IPTG)-induction system. However, the autoinduction resulted higher yield of the enzyme than the conventional induction (27.8%). Techno Economic Analysis revealed that this method could produce MMLV-RT using autoinduction at half the cost of MMLV-RT production by IPTG-induction. Bioprocessing techniques are necessary to conduct to obtain higher quality of MMLV-RT under autoinduction system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Applied Microbiology, National Agency for Research and Innovation, Jl. Raya Bogor, Km. 46, Cibinong, Bogor, 16911, Indonesia.
- Biotechnology Program, Graduate School, IPB University, Bogor, Indonesia.
- Research Center for Applied Microbiology, National Agency for Research and Innovation, Jl. Raya Bogor, Km. 46, Cibinong, Bogor, 16911, Indonesia. fina.amreta.laksmi@gmail.com.
- Research Center for Applied Microbiology, National Agency for Research and Innovation, Jl. Raya Bogor, Km. 46, Cibinong, Bogor, 16911, Indonesia. ade.andriani.44@gmail.com.
- Department of Biology, Faculty of Mathematic and Natural Science, IPB University, Bogor, Indonesia.
- Research Center for Genetic Engineering, National Agency for Research and Innovation, Jl. Raya Bogor, Km. 46, Cibinong, Bogor, 16911, Indonesia.
Förderung
- Lembaga Pengelola Dana Pendidikan
Zitieren
APA
Handayani, C. V., Laksmi, F. A., Andriani, A., Nuryana, I., Mubarik, N. R., Agustriana, E., Dewi, K. S., & Purnawan, A. (2024). Expression of soluble moloney murine leukemia virus-reverse transcriptase in Escherichia coli BL21 star (DE3) using autoinduction system. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09583-6
Vancouver
Handayani CV, Laksmi FA, Andriani A, Nuryana I, Mubarik NR, Agustriana E, et al. Expression of soluble moloney murine leukemia virus-reverse transcriptase in Escherichia coli BL21 star (DE3) using autoinduction system. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09583-6
BibTeX
@article{Handayani2024,
author = {Handayani, Christina Vivid and Laksmi, Fina Amreta and Andriani, Ade and Nuryana, Isa and Mubarik, Nisa Rachmania and Agustriana, Eva and Dewi, Kartika Sari and Purnawan, Awan},
title = {Expression of soluble moloney murine leukemia virus-reverse transcriptase in Escherichia coli BL21 star (DE3) using autoinduction system},
journal = {Molecular Biology Reports},
year = {2024},
volume = {51},
number = {1},
doi = {10.1007/s11033-024-09583-6}
}
EUVIMED